Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health care platform, is ideally situated as the global pandemic has led to a cascade of changes involving how health care is administered, perhaps most notably in the increased adoption of telehealth services. Trxade Group’s business model appears to aptly and effectively meet today’s demands, largely … Continue reading “NetworkNewsBreaks – Trxade Group Inc.’s (NASDAQ: MEDS) Platform Meets Today’s Demands Through Intelligent Design”
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that management will present at the Diamond Equity Research Emerging Growth Invitational. According to the update, the investor conference is scheduled to take place virtually on Dec. 1, 2020. Trxade Group CEO Suren Ajjarapu will, beginning at 3:40 p.m. Eastern … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Host Virtual Presentation at Diamond Equity Research Emerging Growth Invitational”
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that management will present at the Virtual Fall Investor Summit, hosted by Investor Summit Group and taking place November 16-18, 2020. According to the update, Trxade CEO Suren Ajjarapu is scheduled to participate in one-on-one meetings throughout the event and … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Plans to Present at Virtual Fall Investor Summit”
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, has released financial numbers for its third quarter. Financial highlights include third-quarter revenues up by 174% to $6.3 million, compared to revenue of $2.3 million in the same quarter last year; third-quarter gross profit increased 47% to $1.9 million, compared to gross profit of $1.3 … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Releases Q3 2020 Financials, Marks Record Numbers”
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health-care platform, will release financial results for the third quarter ended September 30, 2020, after market close on Monday, October 26, 2020. According to the update, Trxade management will host a conference call to discuss the results at 5:00 p.m. Eastern Time on Monday, October … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Announce Q3 2020 Results, Host Conference Call”
Trxade Group NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, was showcased at several recent virtual conferences and events. In a realm not limited by location, the company’s leadership took advantage of the opportunity to boost exposure of Trxade’s innovative platform and solutions to potential investors. Among capabilities highlighted in the digital spotlight, Trxade’s … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Shines Digital Spotlight on Telehealth Services, Smart Technology”
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health-care platform, today announced that its Bonum Health subsidiary has partnered with SingleCare, the prescription savings service. According to the update, the collaboration is designed to enhance Bonum’s enterprise telehealth solutions with prescription discounts powered by SingleCare. The enterprise service will be offered to national, … Continue reading “NetworkNewsBreaks – Trxade Group Inc.’s (NASDAQ: MEDS) Bonum Health Partners with SingleCare to Enhance Enterprise Telehealth Solutions”
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, assists pharmacies in cutting costs in an era where the pricing of medication poses a major challenge that significantly inflates health-care spending. Trxade’s pharmaceutical trading platform is designed to reduce costs, assisting smaller pharmacies to compete through providing radical price transparency and increased market … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Offers Real-Time Access to Pharmaceuticals to Increase Competition, Reduce Costs”
Pharmaceutical services innovator Trxade Group Inc. has gained investor attention as it has emerged as a responsive healthcare market force during the ongoing COVID-19 pandemic As the pandemic began to unfold earlier this year, Trxade Group saw revenues jump effectively to three times their previous Q1 level, largely as a result of personal protective equipment … Continue reading “Revenue Growth Amid Pandemic Helps Trxade Group, Inc. (NASDAQ: MEDS) Build its Transparency in Pharmaceuticals Strategy”
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, showcased its powerful capabilities during a recent virtual investor summit. Trxade Group’s CEO Suren Ajjarapu presented for the company to discuss the platform, which thrives on its business-to-business (“B2B”) model to provide radical transparency for drug pricing and availability while taking advantage of telehealth-friendly … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) CEO Discusses Strategic Business Models, Nascent Stage of B2C Platform”
